Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,145,636 papers from all fields of science
Search
Sign In
Create Free Account
Gaucher Disease, Type 3 (disorder)
Known as:
GAUCHER DISEASE, TYPE III
, Gaucher Disease, Juvenile and Adult, Cerebral
, Neuronopathic Gaucher Disease
Expand
This type shows moderate to severe neurological effect in childhood.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
13 relations
Ataxia
Autosomal recessive inheritance
Gaucher Disease, Type 2 (disorder)
Mental Depression
Expand
Broader (2)
Gaucher Disease
Lipoidosis
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Glucocerebrosidase Deficiency in Drosophila Results in α-Synuclein-Independent Protein Aggregation and Neurodegeneration
Marie Y. Davis
,
Kien Trinh
,
+6 authors
L. Pallanck
PLoS Genetics
2016
Corpus ID: 40429412
Mutations in the glucosidase, beta, acid (GBA1) gene cause Gaucher’s disease, and are the most common genetic risk factor for…
Expand
Highly Cited
2001
Highly Cited
2001
Gaucher's disease
D. Elstein
,
A. Abrahamov
,
I. Hadas‐Halpern
,
A. Zimran
The Lancet
2001
Corpus ID: 789393
Highly Cited
2000
Highly Cited
2000
Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.
V. Koprivica
,
Deborah L. Stone
,
+5 authors
E. Sidransky
American Journal of Human Genetics
2000
Corpus ID: 22634532
Gaucher disease results from the inherited deficiency of the enzyme glucocerebrosidase (EC 3.2.1.45). Although >100 mutations in…
Expand
Highly Cited
1997
Highly Cited
1997
Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10.
M. Allen
,
B. J. Myer
,
A. Khokher
,
N. Rushton
,
T. Cox
QJM : monthly journal of the Association of…
1997
Corpus ID: 18660844
Gaucher's disease is characterized by hepatosplenomegaly, bone-marrow infiltration, osteonecrosis and bone thinning, associated…
Expand
Highly Cited
1993
Highly Cited
1993
Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 months.
G. Pastores
,
A. Sibille
,
G. Grabowski
Blood
1993
Corpus ID: 28193446
Gaucher disease is the most frequent lysosomal storage disease and the most prevalent genetic disease among the Ashkenazi Jews (q…
Expand
Highly Cited
1989
Highly Cited
1989
PREDICTION OF SEVERITY OF GAUCHER'S DISEASE BY IDENTIFICATION OF MUTATIONS AT DNA LEVEL
A. Zimran
,
E. Gross
,
C. West
,
Joseph A. Sorge
,
M. Kubitz
,
Ernest Beutler
The Lancet
1989
Corpus ID: 21112231
Highly Cited
1988
Highly Cited
1988
Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals.
S. Tsuji
,
B. Martin
,
J. Barranger
,
B. Stubblefield
,
M. Lamarca
,
E. Ginns
Proceedings of the National Academy of Sciences…
1988
Corpus ID: 27096475
Nucleotide sequence analysis of a genomic clone from an Ashkenazic Jewish patient with type 1 Gaucher disease revealed a single…
Expand
Highly Cited
1987
Highly Cited
1987
A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease.
Shoji Tsuji
,
P. Choudary
,
+4 authors
Edward I. Ginns
New England Journal of Medicine
1987
Corpus ID: 43318539
To search for a genetic marker for type 2 Gaucher's disease (acute neuronopathic form), we compared the nucleotide sequence of a…
Expand
Highly Cited
1971
Highly Cited
1971
Gaucher's disease: deficiency of 'acid' -glucosidase and reconstitution of enzyme activity in vitro.
M. Ho
,
J. O'brien
Proceedings of the National Academy of Sciences…
1971
Corpus ID: 38174522
The spleen from a patient with adult Gaucher's disease was shown to be deficient in a beta-glucosidase (EC 3.2.1.21) isoenzyme…
Expand
Highly Cited
1966
Highly Cited
1966
Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease.
R. Brady
,
J. Kanfer
,
R. Bradley
,
D. Shapiro
Journal of Clinical Investigation
1966
Corpus ID: 17183093
The accumulation of abnormal quantities of glucocerebroside in the reticuloendothelial cells of patients with Gaucher's disease…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE